News
Repurposing a Diabetes Medication to Prime CAR T Cancer Targets
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC remains around 5% to 10%. The first FDA-approved antibody-drug conjugate therapy for metastatic UC (mUC)
As Pesticides and Wildfires Rise, Kids with Cancer Need Resources
A growing body of research ties environmental pollutants to worse health and shorter life spans for childhood cancer survivors. Yet medical providers lack sufficient resources to address these risks with patients, a recent federally funded study found. The study, published in Cancers, revealed 80%
UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a combined program focused on cancer outcomes. The program will receive $12 million over five years to
Inaugural Stephenson Global Prize Awards $1 Million to Dr. Frank McCormick for Innovation in Pancreatic Cancer Research
LOS ANGELES--( BUSINESS WIRE)--The inaugural Stephenson Global Prize was awarded to Dr. Frank McCormick, a pioneering scientist whose discoveries have transformed the understanding of RAS-driven cancers. As the pinnacle recognition of innovation in pancreatic cancer research, the Stephenson Global
New Approach for Smarter, Safer Cancer Treatment
While reviewing patients’ charts early in the morning, pediatric hematologist-oncologist Christopher Dvorak, MD, used to feel his heart race when he read about a child with blood cancer getting a stem cell transplant. Stem cells are the body’s building block cells that can develop into other cells
UCSF Trains One of Mexico’s First Specialists to Spot Kids’ Cancer in New Ways
A new grant paves the way for UC San Francisco to train one of Mexico’s first molecular pediatric pathologists, providing access to better cancer detection and treatment for the thousands of children diagnosed with cancer in Mexico every year. The St. Baldrick’s Foundation has awarded Alfonso
UCSF Trains One of Mexico’s First Specialists to Spot Kids’ Cancer in New Ways
A new grant paves the way for UC San Francisco to train one of Mexico’s first molecular pediatric pathologists, providing access to better cancer detection and treatment for the thousands of children diagnosed with cancer in Mexico every year. The St. Baldrick’s Foundation has awarded Alfonso